Sarcoma  >>  socazolimab (STI-A1014)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
socazolimab (STI-A1014) / Sorrento
ChiCTR1800016649: Phase I+II clinical study protocol of recombinant human anti-PD-L1 monoclonal antibody (ZKAB001)

Not yet recruiting
1
21
 
Intravenous infusion ;Intravenous infusion ;Intravenous infusion
the Sixth People's Hospital; Zhaoke (Guang Zhou) Oncology Pharmaceutical Limited, Self-finacing
Osteosarcoma
 
 

Download Options